Abstract
Estrogen replacement therapy is recommended for the prevention of osteoporosis and the attenuation of symptoms associated with menopause. Compliance may be a problem with sequential regimens of estrogen and progestin. To address this issue, continuous-dosing regimens of estrogen and progestin have been used. These regimens cause significantly less cyclic and intermenstrual bleeding and induce amenorrhea in most women, which should enhance compliance.
Original language | English (US) |
---|---|
Pages (from-to) | 1519-1523 |
Number of pages | 5 |
Journal | American family physician |
Volume | 50 |
Issue number | 7 |
State | Published - Dec 14 1994 |
ASJC Scopus subject areas
- Family Practice